CPP may incorporate genetic alterations, such as MKRN3, DLK1, and KISS1; mutations in the epigenetic factors that regulate the HPG axis, such as Lin28b and Let 7; syndromes; central lesions such as hypothalamic hamartoma; and others. This evidence concerns the gene DLK1 and congenital hypothalamic hamartoma syndrome.